Pharmacogenetics of the PPAR genes and cardiovascular disease.

Item

http://www.wikidata.org/entity/Q37012017

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@en

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@nl

type

Item

label

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@en

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@nl

prefLabel

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@en

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@nl

P1476

Pharmacogenetics of the PPAR genes and cardiovascular disease.

@en

P2093

Sharon Cresci

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

PPAR delta: an uncompletely known nuclear receptor

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

PPAR delta: a dagger in the heart of the metabolic syndrome.

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR

P304

1581-1595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.8.11.1581

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18034623

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease